Studies have shown that NONO can regulate the alternative splicing of the tumor suppressor PTEN pre-mRNA, where elevated NONO expression promotes the production of a functionally impaired PTEN isoform, leading to sustained activation of the PI3K/AKT signaling pathway and, consequently, enhanced tumor proliferation and invasion [23]. The gene discussed is AKT1; the disease is neoplasm.